A prospective, randomized, parallel, two-stage,, single center trial study to evaluate the safety, immunogenicity and reactogenicity of combination Hib-DTaP-vaccine in chinese infants and toddlers

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 25 Aug 2015

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

25 Aug 2015 The data from this trial will provide support to licence of this vaccine in china as per results published in the Vaccine.
25 Aug 2015 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com